2025-05-16 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc. (ISRG) based on the provided data.

## Intuitive Surgical Inc. (ISRG) Analysis

**1. Performance Overview**

*   **Ticker:** ISRG
*   **Company:** Intuitive Surgical Inc
*   **Description:**  A pioneer in robotic-assisted surgery, designing, manufacturing, and marketing the da Vinci surgical system.

**Key Performance Numbers:**

*   **ISRG Cumulative Return:** 141.29%
*   **S&P 500 (VOO) Cumulative Return:** 81.82%
*   **Spread:** 59.5
*   **Relative Spread Position:** 51.6 (Indicates the spread is positioned near the median of its historical range.)

**ISRG vs. S&P 500 Performance Analysis:**

ISRG has significantly outperformed the S&P 500 over the analyzed period. The spread of 59.5% indicates a substantial performance difference. However, the relative spread position of 51.6 suggests that while ISRG is outperforming, the current outperformance is around the median compared to its historical performance relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 56.5% | 38.0% | 0.0 | 43.6 |
| 2016-2018  | 77.0% | 63.4% | 60.0% | 0.0 | 57.2 |
| 2017-2019  | 81.0% | 63.4% | 52.0% | 0.3 | 70.6 |
| 2018-2020  | 47.0% | 63.4% | 22.0% | 0.2 | 97.8 |
| 2019-2021  | 91.0% | 63.0% | 37.0% | 0.3 | 128.8 |
| 2020-2022  | -3.0% | 69.9% | -9.0% | 0.3 | 95.1 |
| 2021-2023  | -5.0% | 72.9% | -22.0% | 1.0 | 120.9 |
| 2022-2024  | 26.0% | 72.9% | 9.0% | 1.0 | 187.1 |
| 2023-2025  | 62.0% | 72.9% | 33.0% | 0.7 | 200.6 |

**Analysis:**

*   **CAGR:** High growth rates in earlier periods, with some recent periods showing negative growth, then resurgence.
*   **MDD:** Maximum Drawdown is consistently high, indicating significant volatility.
*   **Alpha:** Positive alpha in most periods suggests outperformance relative to risk-adjusted benchmarks, but negative alpha in 2020-2023.
*   **Beta:** Low Beta values ​​in the early stages and high Beta values ​​in the recent indicate increased correlation with the market.
*   **Cap:** Market capitalization has grown significantly over the periods.

**2. Recent Stock Price Movement**

*   **Current Price:** 559.645
*   **Last Market Data:** Price: 559.06, Previous Close: 565.94, Change: -1.22
*   **5-Day Moving Average:** 546.379
*   **20-Day Moving Average:** 514.7768
*   **60-Day Moving Average:** 518.6516

**Analysis:**

The current price is above all moving averages, suggesting an upward trend.  The recent price decrease (-1.22) and the fact that the 5-day moving average is above the 20 and 60-day moving averages, indicates recent bullish momentum.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.35 (Low Risk)
*   **RSI:** 93.48 (Overbought)
*   **PPO:** 1.09
*   **Recent (20-day) Relative Spread Change:** 3.0 (Positive - Short-term increase)
*   **Expected Return:** 36.7%

**Analysis:**

*   The low MRI suggests that the overall market risk is low.
*   A very high RSI (93.48) indicates that the stock is significantly overbought and may be due for a correction.
*   The PPO being above zero suggests that the short-term moving average is above the long-term moving average, which indicates an upward trend.
*   The positive change in relative spread indicates recent outperformance compared to the S&P 500.
*   The high Expected Return suggests potential for significant outperformance relative to the S&P 500 over the long term if investing now.

The negative change in the recent market data may reflect immediate market responses and should be considered in short-term investment decisions.

**4. Recent News & Significant Events**

*   **May 12, 2025:**  Major business developments, regulatory changes, or market events.
*   **May 13, 2025:** Analyst discussion on ISRG performance and outlook.
*   **May 15, 2025:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **May 14, 2025:**  Market experts highlight risks and opportunities.

**Analysis:** The news suggests that ISRG is currently experiencing a period of heightened activity and attention, which could be contributing to the recent volatility. Keep abreast of company announcements.

**5. Recent Earnings Analysis**

| 날짜         | EPS   | 매출      |
|--------------|-------|-----------|
| 2025-04-23   | 1.95  | 2.25 B$   |
| 2024-10-18   | 1.59  | 2.04 B$   |
| 2024-07-19   | 1.48  | 2.01 B$   |
| 2024-04-19   | 1.54  | 1.89 B$   |
| 2025-04-23   | 1.54  | 1.89 B$   |

**Analysis:**

*   The latest EPS (1.95) shows a significant increase compared to previous quarters.
*   Revenue has also shown consistent growth, indicating strong business performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |
| 2024-06-30 | $2.01B    | 68.30%        |
| 2024-03-31 | $1.89B    | 65.87%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-03-31 | $17.11B   | 4.08%   |
| 2024-12-31 | $16.43B   | 4.17%   |
| 2024-09-30 | $15.58B   | 3.63%   |
| 2024-06-30 | $14.71B   | 3.58%   |
| 2024-03-31 | $13.96B   | 3.90%   |

**Analysis:**

*   **Revenue:** Demonstrates a growth trend, although Q1 2025 is slightly lower than Q4 2024.
*   **Profit Margin:** Consistently high, indicating strong profitability.
*   **Equity:** Increasing steadily.
*   **ROE:** Relatively stable.

**7. Overall Analysis**

Intuitive Surgical (ISRG) presents a mixed picture:

*   **Strengths:** Strong long-term performance relative to the S&P 500, solid revenue and profit margins, growing equity, and potential for long-term outperformance.
*   **Weaknesses:** Recent overbought conditions (high RSI), high maximum drawdowns indicating volatility, and sensitivity to recent market news.

**Recommendations:**

*   **Short-term:** Be cautious due to the overbought RSI and recent price decrease.  A correction is possible.
*   **Long-term:** ISRG appears to be a potentially good investment for long-term investors, given its strong financial performance and growth potential.  The expected return of 36.7% is promising. Consider incremental investing to take advantage of potential dips.
*   **Monitoring:** Closely monitor news and analyst reports regarding ISRG, especially concerning regulatory changes, market events, and earnings reports.

This analysis is based on the provided data and should be supplemented with further research and professional financial advice.
